Now hiring: Director of Research
Tuesday, 4 July 2017
Access to Medicine Foundation
The Access to Medicine Foundation is looking for an experienced Director of Research to oversee all research undertaken by the Access to Medicine Foundation, such as the Access to Medicine Index, the Access to Vaccines Index, the Antimicrobial Resistance Benchmark and other publications.
More about Research at the Foundation
The Access to Medicine Foundation analyses and compares pharmaceutical companies’ policies and practices regarding access to medicine in low- and middle-income countries. We benchmark companies against each other, and identify best practices and progress gaps. Our main research programmes in the next two years are the 2018 Access to Medicine Index and the first Antimicrobial Resistance Benchmark.
The Access to Medicine Index is a biennial evaluation of 20 of the world’s largest research-based pharmaceutical companies. The Antimicrobial Research Benchmark is a new tool that will track how pharmaceutical, generic and biopharmaceutical companies are responding to the global increase in drug-resistance. The Foundation also publishes the first Access to Vaccines Index, and thematic studies focused on priority access topics, such as improving access to cancer care.
These research programmes each have a dedicated Research Programme Manager, leading a team of four to five researchers.
Salary: Commensurate with experience
Position: Director of Research
Contract: 1 year, renewable
Location: Amsterdam, the Netherlands
Experience: 5 years
About the Role
We are looking for a Director of Research to oversee the Foundation’s research programmes, and lead the different Research Programme Managers responsible for each of the research programmes. The Director of Research will sit on the Foundation’s Management Team. The main responsibilities include:
- Ensuring the research programmes are steered toward our strategic goals and mission of the Foundation
- Bearing overall responsibility for the Foundation’s research programmes, including the production of the Access to Medicine Index and Antimicrobial Resistance Benchmark;
- Supervising the work of the Research Programme Managers for the different research programmes, and ensuring the excellent quality of the programme outputs;
- Coordinating the research of the Foundation with other global health initiatives, such as those of Health NGOs, multilateral organisations (WHO, Gavi, Unicef, UN agencies, etc.);
- Managing the development of the different methodologies for each research programme, through a comprehensive process of multi-stakeholder dialogue and expert consultation;
- Ensuring an efficient process of data-collection and analysis;
- Developing and maintaining the Foundation’s relationship with other stakeholders in the fields of global health and pharmaceuticals;
- Representing the research work of the Foundation, namely the Indexes and Benchmark, at conferences and external events; and
- Collaborating efficiently with the Management Team and other staff members responsible for coordinating the operations of the Foundation and leading its engagement with pharmaceutical companies.
The Director of Research will report to the Executive Director, and take on the management of the Research Programme Managers and Operations. The salary will be commensurate to the experience of the candidate.
Profile and essential skills
- A PhD, medical and/or pharmacy degree and evidence of long-term research experience – in health-related fields;
- At least 5 years’ work experience with the pharmaceutical industry; experience of working in global health teams within the industry is welcome;
- Publications on health-related topics in top-level media, academic journals and other outlets;
- Profound knowledge of global health, pharmaceuticals and the pharmaceutical and vaccine business;
- At least 5 years’ experience leading teams, managing operations, resource and budget planning and directing research projects;
- Excellent command of English, both spoken and written, with the proven ability to translate academic research for a wider audience;
- Skilled in both advanced quantitative and qualitative analyses;
- Team player, willing to go the extra mile; and
Available to start at the latest on 1 September, 2017.
Interested candidates should send a CV, contacts of two references and two original writing samples to Mireille Deen, firstname.lastname@example.org. Applications will be reviewed on a rolling basis, and interviews will begin in July 2017.
About the Access to Medicine Index
The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies with products for high-burden diseases in low- and middle-income countries. The Index ranks these companies according to their efforts to improve access to medicine in seven areas of corporate behaviour, including pricing, patents, ethical behaviour and donations. It covers 107 low- and middle-income countries and 50 high-burden diseases, and examines eight types of products, from medicines to vaccines to diagnostics. The Index identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. In this way, the Index provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. It is published every two years by the Access to Medicine Foundation, an independent non-profit organisation.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent, non-profit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index was published in November 2016. In 2017, the Foundation has published the first Access to Vaccines Index, funded by the Dutch National Postcode Lottery, the first analysis of pharma company approaches to cancer care in low and middle-income countries, and will publish the first Antimicrobial Benchmark, funded by the UK and Dutch governments.